Patterns of Comorbidities in Lung Cancer Patients and Survival
The adverse impact of comorbidities on NSCLC-specific mortality requires their inclusion as risk factors in cancer treatment and prognosis.
Authors
- Manuel Zorzi (ORCID: https://orcid.org/0000-0001-6025-5214)
- Ilaria Pantaleo
- Valentina Guarneri (ORCID: https://orcid.org/0000-0002-2375-8397)
- Pierfranco Conté (ORCID: https://orcid.org/0000-0002-5210-5344)
- Federico Rea (ORCID: https://orcid.org/0000-0001-7988-5101)
- Massimo Rugge
- Giovanna Scroccaro (ORCID: https://orcid.org/0000-0002-6438-8521)
- Alessandra Buja (ORCID: https://orcid.org/0000-0003-2216-3807)
- Giorgio Arcara (ORCID: https://orcid.org/0000-0001-6270-6883)
- Leonardo Rigon (ORCID: https://orcid.org/0000-0002-1986-3389)
- Giulia Pasello (ORCID: https://orcid.org/0000-0002-8741-6038)
- Marcello Di Pumpo (ORCID: https://orcid.org/0000-0003-3037-0726)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Padua (IT)
- Istituto Oncologico Veneto (IT)
- IRCCS San Camillo Hospital (IT)
- Regione del Veneto (IT)
Publication Details
- Journal
- Cancers
- Published
- 2025-05-06
- DOI
- https://doi.org/10.3390/cancers17091577
- Citations
- 4
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 6.07